Insulin-like growth factor i gene transfer to cirrhotic liver induces fibrolysis and reduces fibrogenesis leading to cirrhosis reversion in rats

Hepatology

Volumn 51, Issue 3, 2010, Pages 912-921

  Sobrevals, Luciano ^a   Rodriguez, Carlos ^a   Romero Trevejo, Jośe Lorenzo ^a   Gondi, Gabor ^a   Monreal, Ĩnaki ^a   Pãneda, Astrid ^a   Juanarena, Nerea ^a   Arcelus, Sara ^a   Razquin, Nerea ^a   Guembe, Laura ^a   Gonźalez Aseguinolaza, Gloria ^a   Prieto, Jeśus ^a,b   Fortes, Puri ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; AMPHIREGULIN; CARBON TETRACHLORIDE; CONNECTIVE TISSUE GROWTH FACTOR; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; LUCIFERASE; PLATELET DERIVED GROWTH FACTOR; SCATTER FACTOR; SODIUM CHLORIDE; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; THIOACETAMIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN; VIRUS VECTOR; WT1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROTECTION; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROGENESIS; GENE TRANSFER; LIVER CELL; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER FUNCTION; LIVER FUNCTION TEST; LIVER HISTOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIMIAN VIRUS 40; UPREGULATION;

EID: 77950606617     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.23412     Document Type: Article

References (31)

1. Freeman RB Jr, Steffick DE, Guidinger MK, Farmer DG, Berg CL, Me-rion RM. Liver and intestine transplantation in the United States, 1997-2006. Am J Transplant 2008;8:958-976.
2. Mohan S, Baylink DJ. IGF-binding proteins are multifunctional and act via IGF-dependent and-independent mechanisms. J Endocrinol 2002; 175:19-31.
3. Riedemann J, Macaulay VM. IGF1R signalling and its inhibition. Endocr Relat Cancer 2006;13(Suppl 1):S33-S43.
4. Conchillo M, de Knegt RJ, Payeras M, Quiroga J, Sangro B, Herrero JI, et al. Insulin-like growth factor I (IGF-I) replacement therapy increases albumin concentration in liver cirrhosis: results of a pilot randomized controlled clinical trial. J Hepatol 2005;43:630-636.
5. Castilla-Cortazar I, Prieto J, Urdaneta E, Pascual M, Nunez M, Zudaire E, et al. Impaired intestinal sugar transport in cirrhotic rats: correction by low doses of insulin-like growth factor I. Gastroenterology 1997;113:1180-1187.
6. Castilla-Cortazar I, Garcia M, Muguerza B, Quiroga J, Perez R, Santidrian S, et al. Hepatoprotective effects of insulin-like growth factor I in rats with carbon tetrachloride-induced cirrhosis. Gastroenterology 1997;113:1682-1691.
7. Vera M, Sobrevals L, Zaratiegui M, Martinez L, Palencia B, Rodriguez CM, et al. Liver transduction with a simian virus 40 vector encoding insulin-like growth factor I reduces hepatic damage and the development of liver cirrhosis. Gene Ther 2007;14:203-210.
8. Avila MA, Carretero MV, Rodriguez EN, Mato JM. Regulation by hyp-oxia of methionine adenosyltransferase activity and gene expression in rat hepatocytes. Gastroenterology 1998;114:364-371.
9. Friedman SL, Roll FJ. Isolation and culture of hepatic lipocytes, Kupffer cells, and sinusoidal endothelial cells by density gradient centrifugation with Stractan. Anal Biochem 1987;161:207-218.
10. Runyon BA, Sugano S, Kanel G, Mellencamp MA. A rodent model of cirrhosis, ascites, and bacterial peritonitis. Gastroenterology 1991;100: 489-493.
11. de Leeuw AM, McCarthy SP, Geerts A, Knook DL. Purified rat liver fat-storing cells in culture divide and contain collagen. HEPATOLOGY 1984; 4:392-403.
12. De Minicis S, Seki E, Uchinami H, Kluwe J, Zhang Y, Brenner DA, et al. Gene expression profiles during hepatic stellate cell activation in culture and in vivo. Gastroenterology 2007;132:1937-1946.
13. Friedman SL. Mechanisms of disease: mechanisms of hepatic fibrosis and therapeutic implications. Nat Clin Pract Gastroenterol Hepatol 2004;1: 98-105.
14. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000;275:2247-2250.
15. Friedman SL. Liver fibrosis \ from bench to bedside. J Hepatol 2003; 38(Suppl 1):S38-S53.
16. Perugorria MJ, Latasa MU, Nicou A, Cartagena-Lirola H, Castillo J, Goni S, et al. The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis. HEPATOLOGY 2008;48: 1251-1261.
17. Ueki T, Kaneda Y, Tsutsui H, Nakanishi K, Sawa Y, Morishita R, et al. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med 1999;5:226-230. (Pubitemid 29068532)
18. Perugorria MJ, Castillo J, Latasa MU, Goni S, Segura V, Sangro B, et al. Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy. Cancer Res 2009;69: 1358-1367.
19. Berasain C, Herrero JI, Garcia-Trevijano ER, Avila MA, Esteban JI, Mato JM, et al. Expression of Wilms' tumor suppressor in the liver with cirrhosis: relation to hepatocyte nuclear factor 4 and hepatocellular function. HEPA-TOLOGY 2003;38:148-157.
20. Ryffel GU. Mutations in the human genes encoding the transcription factors of the hepatocyte nuclear factor (HNF)1 and HNF4 families: functional and pathological consequences. J Mol Endocrinol 2001;27: 11-29.
21. Vera M, Fortes P. Simian virus-40 as a gene therapy vector. DNA Cell Biol 2004;23:271-282.
22. Caro JF, Poulos J, Ittoop O, Pories WJ, Flickinger EG, Sinha MK. Insulinlike growth factor I binding in hepatocytes from human liver, human hepatoma, and normal, regenerating, and fetal rat liver. J Clin Invest 1988; 81:976-981.
23. Scharf JG, Knittel T, Dombrowski F, Muller L, Saile B, Braulke T, et al. Characterization of the IGF axis components in isolated rat hepatic stellate cells. HEPATOLOGY 1998;27:1275-1284.
24. Long L, Navab R, Brodt P. Regulation of the Mr 72,000 type IV collage-nase by the type I insulin-like growth factor receptor. Cancer Res 1998; 58:3243-3247.
25. Liu X, Hu H, Yin JQ. Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis. Liver Int 2006;26:8-22.
26. Issa R, Zhou X, Constandinou CM, Fallowfield J, Millward-Sadler H, Gaca MD, et al. Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking. Gas-troenterology 2004;126:1795-1808.
27. Asselah T, Bieche I, Laurendeau I, Paradis V, Vidaud D, Degott C, et al. Liver gene expression signature of mild fibrosis in patients with chronic hepatitis C. Gastroenterology 2005;129:2064-2075. (Pubitemid 41772981)
28. Elsharkawy AM, Mann DA. Nuclear factor-kappaB and the hepatic in-flammation-fibrosis-cancer axis. HEPATOLOGY 2007;46:590-597.
29. Yeh CN, Maitra A, Lee KF, Jan YY, Chen MF. Thioacetamide-induced intestinal-type cholangiocarcinoma in rat: an animal model recapitulating the multi-stage progression of human cholangiocarcinoma. Carcinogenesis 2004;25:631-636.
30. Mazziotti G, Sorvillo F, Morisco F, Carbone A, Rotondi M, Stornaiuolo G, et al. Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study. Cancer 2002;15:2539-2545.
31. Scharf JG, Braulke T. The role of the IGF axis in hepatocarcinogenesis. Horm Metab Res 2003;35:685-693.